A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Eilean Therapeutics
National Cancer Institute (NCI)
University of Alabama at Birmingham
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
University of Rochester
City of Hope Medical Center
Center for International Blood and Marrow Transplant Research
Novartis
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Dana-Farber Cancer Institute
MPN Research Foundation
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Stanford University
City of Hope Medical Center
City of Hope Medical Center
Incyte Corporation
Thomas Jefferson University
Thomas Jefferson University
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Mayo Clinic
Constellation Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
University Hospital, Bordeaux
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Celgene
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
American Regent, Inc.
City of Hope Medical Center
City of Hope Medical Center